Dr. Jonathan Andrew Schor, MD

Dr. Schor practices at Staten Island University Hospital - North Campus in Staten Island, New York.

Dr. Schor's NPI, 1902097157, was assigned on August 5, 2007. Dr. Schor graduated from State University of New York Downstate Medical Center in 2003. Dr. Schor holds New York license 236577.

Dr. Schor's primary practice is Staten Island University Hospital - North Campus, at 475 Seaview Ave, Staten Island, NY 10305 in Richmond County. The practice phone is (718) 226-4502.

Dr. Schor's primary practice is Staten Island University Hospital - North Campus in Staten Island, New York. Dr. Schor is also affiliated with Staten Island University Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Schor to 2 more group practices and clinics, 2 home health agencies and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schor practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Schor's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Schor is licensed in New York.

CMS data shows 3,144 Medicare services from Dr. Schor across 21 procedure codes in 2024, for 1,751 Medicare patients. Medicare paid $226,718 for them.

CMS counts 1,751 Medicare patients who saw Dr. Schor in 2024. The largest group is 75 to 84, with 686 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schor's median patient age at 73, with 47% women.

In 2024, Dr. Schor wrote 76 Medicare Part D claims for 35 patients. 47% of them were for generic drugs. CMS names the drug for 48 of them, across 3 drugs with 11 or more claims each, at $48,382 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Schor for performance year 2024, reported through an alternative payment model (APM). Dr. Schor accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 20 procedures of leg revascularization (restoring blood flow) by Dr. Schor, more than 80% of the clinicians it reports for that procedure.

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 23 papers to Dr. Schor, published from 2015 to 2024. 2020 was the busiest year, with 6. The most frequent topics are Thrombolytic Therapy, Venous Thrombosis and Iliac Vein. Dr. Schor has published most often in Ann Vasc Surg. Dr. Schor's most frequent co-authors are Jonathan S. Deitch, MD, Hamid Reza Mojibian, MD and Matthew C. Bunte, MD.

Dmand AI links Dr. Schor to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Gangrene, Postthrombotic Syndrome and Chronic Limb-Threatening Ischemia.

CMS Open Payments shows 146 general payments to Dr. Schor from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. W. L. Gore & Associates, Inc. paid the most, $2,339.

Dr. Schor graduated from State University of New York Downstate Medical Center in 2003.